Clinical Trial Update: Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial compares micro-dose human chorionic gonadotropin (hCG) with human menopausal gonadotropin (hMG) in Polycystic Ovary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Human menopausal gonadotropin (hMG) (human menopausal gonadotropin)
• micro-dose human chorionic gonadotropin (hCG) (human chorionic gonadotropin)

Snippet

Sponsor: Royan Institute | Conditions: Endocrine System Diseases, Gonadal Disorders | Phase 1, Phase 2 | Status: COMPLETED